The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug and Cosmetic Act requires this notice.
In most cases (and in all cases in which the coffee shop doesn’t want to risk being sued), coffee shops can’t advertise CBD as doing much of anything, one way or another. While clinical trials attempt to determine an effective dose for a particular condition, says Esther, the growing “wellness empire” is free to leave the effects to your imagination. “People who are selling CBD don’t even have to make specific claims. The relationship between the actual amount of CBD and the effect doesn’t have to be very specific, because there is no specific effect that they’re talking about,” says Blessing. “So if I have a CBD latte, I might feel a little relaxed, or a little less neurotic, or who knows.”
CBD has noted effects on many systems the brain uses to send signals to your body. One of these is the endocannabinoid system. When used, CBD can have beneficial effects on people who suffer neurological disorders. The research in this area is still new. However, there were many studies where CBD was tested for its effect on treating MS and epilepsy.
The limited studies out there indicate that CBD has, in its various interactions with the brain and immune system, some anti-inflammatory and anti-anxiety effects. It can balance out the effects of THC by reducing the anxiety THC sometimes brings, and many in the industry are big on “broad spectrum” or “full spectrum” configurations, which use many cannabinoids at once.
On a sunny but unseasonably freezing April afternoon in New York, I walked the 10 or so minutes from the L train to Caffeine Underground, a coffee shop in Bushwick that triples as an art gallery and community center. The open-concept space serves lattes and espressos and a variety of milks (oat, almond, macadamia) and plenty of “wellness” options (Kava tea, Bulletproof-style coffee, activated charcoal add-ins). But there’s one totally unique item: Cannabidiol-infused (CBD) coffee.
Despite this, CBD is something nobody knows much about, and certainly nobody is monitoring it properly. CBD is widely marketed as a supplement, despite the Food and Drug Administration saying it does not qualify as such (this is because it is an active ingredient in drugs which are either approved or under investigation to be approved). CBD goes largely unregulated by the agency; on the FDA’s FAQ page, a vague answer maintains there are “many factors in deciding whether or not to initiate an enforcement action.” The Department of Agriculture handles research grants and pilot programs for hemp, but that’s where its involvement ends.